Clinical and molecular correlates of JAK-inhibitor therapy failure in myelofibrosis: long-term data from a molecularly annotated cohort

Leukemia. 2022 Jun;36(6):1689-1692. doi: 10.1038/s41375-022-01544-x. Epub 2022 Mar 26.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cohort Studies
  • Humans
  • Janus Kinase 2 / genetics
  • Janus Kinase Inhibitors* / therapeutic use
  • Janus Kinases
  • Nitriles / therapeutic use
  • Primary Myelofibrosis* / drug therapy
  • Primary Myelofibrosis* / genetics
  • Protein Kinase Inhibitors / therapeutic use

Substances

  • Janus Kinase Inhibitors
  • Nitriles
  • Protein Kinase Inhibitors
  • Janus Kinase 2
  • Janus Kinases